XML 53 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
1 Months Ended 12 Months Ended
May 25, 2016
Jun. 18, 2009
Nov. 30, 2016
May 31, 2018
May 31, 2017
Apr. 30, 2018
Jan. 31, 2018
Nov. 30, 2017
Oct. 31, 2016
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Stock Issued During Period, Value, New Issues       $ 1,275,933          
Vanderbilt University Medical Center [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Startup Costs                 $ 85,000
University OF Michigan [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Startup Costs               $ 181,015  
Beth Israel Deaconess Medical Center [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Startup Costs             $ 142,000    
Guardian Angel Research Center [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Startup Costs           $ 75,400      
Royalty Agreements [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Royalty Expense       $ 19,000 $ 19,000        
Royalty Expense Percentage Of Sales       2.60% 2.50%        
Exclusive Marketing License Agreement [Member] | US FDA [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Clearance Fees       $ 1,250,000          
Conversion of Stock, Amount Converted       $ 250,000          
Shares Issued, Price Per Share (in Dollars per share)       $ 3.00          
Conversion of Stock, Shares Issued (in Shares)       83,333          
Exclusive Marketing License Agreement [Member] | Korean FDA [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Royalty Expense       $ 7,250,000          
Agreement Term Period       5 years          
Building In Irvine California [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Operating Lease Initiation Date   Sep. 01, 2009              
Lease Expiration Date   Aug. 31, 2016              
Property Available for Operating Lease [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Operating Leases, Rent Expense     $ 2,926            
Lease Expiration Period     10 years            
UNITED STATES | Property Available for Operating Lease [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Operating Leases, Rent Expense       $ 268,550 $ 260,393        
MEXICO | Property Available for Operating Lease [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Operating Leases, Rent Expense       $ 45,963 $ 44,986        
First Amendment To Lease [Member] | Building In Irvine California [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Lease Expiration Date       Aug. 31, 2021          
Operating Leases, Rent Expense, Minimum Rentals       $ 21,000          
Operating Leases, Rent Expense       23,637          
Security Deposit       $ 22,080          
Exclusive Marketing License Agreement [Member] | Private Placement [Member] | Celtis Pharm Co., Ltd [Member]                  
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                  
Shares Issued, Price Per Share (in Dollars per share) $ 3.00                
Stock Issued During Period, Shares, New Issues (in Shares) 333,334                
Stock Issued During Period, Value, New Issues $ 1,000,002